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Abstract: Angiotensin I-converting enzyme (ACE) hydrolyzes numerous peptides and is a critical partici-
pant in blood pressure regulation and vascular remodeling. Elevated tissue ACE levels are associated with
increased risk for cardiovascular and respiratory disorders. Blood ACE concentrations are determined
by proteolytic cleavage of ACE from the endothelial cell surface, a process that remains incompletely
understood. In this study, we identified a novel ACE gene mutation (Arg532Trp substitution in the N
domain of somatic ACE) that increases blood ACE activity 7-fold and interrogated the mechanism by
which this mutation significantly increases blood ACE levels. We hypothesized that this ACE mutation
disrupts the binding site for blood components which may stabilize ACE conformation and diminish ACE
shedding. We identified the ACE-binding protein in the blood as lysozyme and also a Low Molecular
Weight (LMW) ACE effector, bilirubin, which act in concert to regulate ACE conformation and thereby
influence ACE shedding. These results provide mechanistic insight into the elevated blood level of ACE
observed in patients on ACE inhibitor therapy and elevated blood lysozyme and ACE levels in sarcoidosis
patients.
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Lysozyme and bfiflfirubfin bfind to ACE 
and reguflate fits confformatfion and 
sheddfing
Sergefi M. Danfiflov1,2, Hefinrfich Lünsdorff3, Henry T. Akfinbfi4, Andrew B. Nesterovfitch5, 
Yuflfiya Epshtefin2, Eflefftherfia Letsfiou2, Oflga V. Kryukova6, Tobfias Pfiegefler1,7, 
Eflena Z. Goflukhova8, Davfid E. Schwartz1, Randafl O. Duflfl1, Rfichard D. Mfinshaflfl1,9, 
Oflga A. Kost6 & Joe G. N. Garcfia2,10
Angfiotensfin I-convertfing enzyme (ACE) hydroflyzes numerous peptfides and fis a crfitficafl partficfipant fin 
bflood pressure reguflatfion and vascuflar remodeflfing. Eflevated tfissue ACE flevefls are assocfiated wfith 
fincreased rfisk ffor cardfiovascuflar and respfiratory dfisorders. Bflood ACE concentratfions are determfined 
by proteoflytfic cfleavage off ACE ffrom the endotheflfiafl ceflfl surfface, a process that remafins fincompfletefly 
understood. In thfis study, we fidentfified a novefl ACE gene mutatfion (Arg532Trp substfitutfion fin the N 
domafin off somatfic ACE) that fincreases bflood ACE actfivfity 7-ffofld and finterrogated the mechanfism by 
whfich thfis mutatfion sfignfificantfly fincreases bflood ACE flevefls. We hypothesfized that thfis ACE mutatfion 
dfisrupts the bfindfing sfite ffor bflood components whfich may stabfiflfize ACE confformatfion and dfimfinfish 
ACE sheddfing. We fidentfified the ACE-bfindfing protefin fin the bflood as flysozyme and aflso a Low Moflecuflar 
Wefight (LMW) ACE effector, bfiflfirubfin, whfich act fin concert to reguflate ACE confformatfion and thereby 
finfluence ACE sheddfing. These resuflts provfide mechanfistfic finsfight finto the eflevated bflood flevefl off ACE 
observed fin patfients on ACE finhfibfitor therapy and eflevated bflood flysozyme and ACE flevefls fin sarcofidosfis 
patfients.
Te extraceflfluflar domafins off dfiverse membrane-anchored protefins, such as tumor necrosfis ffactor α recep-
tor (TNFR-α ), L-seflectfin, ACE are refleased ffrom the ceflfl surfface as soflubfle protefins through a reguflated pro-
teoflytfic mechanfism - ectodomafin sheddfing. Ceflfl surfface proteases such as the ADAMs (A Dfisfintegrfin And 
Metaflfloprotefinase), as weflfl as a varfiety off moflecuflar fintra-and extraceflfluflar finteractfions, reguflate thfis process1.
Angfiotensfin-convertfing enzyme (ACE, CD143, EC 3.4.15.1), a Zn2+ carboxydfipeptfidase wfith two cataflytfic 
centers2, fis a crfitficafl reguflator off bflood pressure and vascuflar remodeflfing3,4. Somatfic ACE fis expressed on the 
surfface off endotheflfiafl and specfiffc epfitheflfiafl ceflfls, as weflfl as macrophages and dendrfitfic ceflfls3–5. Apart ffrom 
membrane-bound ACE, bflood and other bfioflogficafl ffufids contafin a varfiabfle amount off soflubfle ACE. Bflood ACE 
orfigfinates prfimarfifly ffrom the vast puflmonary mficrovascuflature that exhfibfits 100% ACE expressfion compared to 
10–15% ACE-posfitfive capfiflflarfies fin the systemfic cfircuflatfion6. ACE enters the cfircuflatfing poofl vfia sheddfing ffrom 
the endotheflfiafl ceflfl surfface by an as yet unfidentfiffed ACE secretase7. In heaflthy findfivfiduafls, the concentratfion off 
ACE fin the bflood fis stabfle8 whereas sfignfiffcantfly fincreased bflood ACE fis observed fin subjects wfith sarcofidosfis or 
Gaucher dfisease, consequentfly servfing as a cflfinficafl bfiomarker off dfisease severfity9.
We fidentfiffed severafl ACE gene mutatfions that fincrease bflood ACE flevefls (5–14 ffofld) fincfludfing a mutatfion fin 
the staflk regfion fleadfing to greater ACE cfleavage effcfiency ffrom the ceflfl surfface10, mutatfions eflfimfinatfing expres-
sfion off the transmembrane anchor and, thereffore, resufltfing fin dfirect ACE secretfion finto the cfircuflatfion11,12, and 
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a mutatfion resfidfing at the finterfface off the N domafin dfimers (Y465D), affectfing ACE dfimerfizatfion and flfikeflyfin-
creasfing accessfibfiflfity off the staflk regfion to the ACE secretase13.
In thfis study, we fidentfiffed a novefl ACE gene mutatfion (Arg532Trp) that fincreases bflood ACE actfivfity (7-ffofld) 
and finterrogated the mechanfism by whfich thfis mutatfion sfignfiffcantfly fincreases bflood ACE flevefls. We proposed 
a novefl reguflatfion off ACE confformatfion, and as a consequence, ACE sheddfing vfia dfirect bfindfing off cfircuflatfing 
bflood components - flysozyme and bfiflfirubfin to ACE.
Prfior reports fincfluded severafl fintraceflfluflar ACE-bfindfing protefins - GRP78 (BfiP), rfibophorfin 1, specfiffc pro-
tefin kfinase C fisofforms14, caflmoduflfin15, ß-actfin, non-muscfle myosfin heavy chafin IIA16, fintegrfins B1 and A517, as 
weflfl as an unfidentfiffed ACE-bfindfing protefin (14 kDa) fin human serum18.
We now report the fidentfiffcatfion off flysozyme and bfiflfirubfin as ACE-bfindfing bflood components that act fin con-
cert to reguflate ACE confformatfion and flfikefly finffuence on ACE sheddfing. Tese resuflts convey severafl bfioflogficafl 
and therapeutfic ramfiffcatfions fincfludfing a potentfiafl expflanatfion ffor eflevated bflood ACE flevefl fin patfients on ACE 
finhfibfitor therapy.
Resuflts and DfiscussfionNovefl ACE mutatfion assocfiated wfith eflevated bflood ACE actfivfity. Screenfing ffor ACE actfivfity fin 
pflasma ffrom 84 patfients wfith sarcofidosfis resuflted fin the fidentfiffcatfion off a case (#38) wfith markedfly fincreased 
ACE actfivfity (7-ffofld vs. controfl) (Ffig. 1A). We expflored potentfiafl mutatfions fin the staflk regfion off ACE causfing 
enhancement off fits sheddfing19. Immunoprecfipfitatfion off ACE actfivfity ffrom the #38 pflasma utfiflfizfing monocflonafl 
antfibodfies (mAbs) dfirected to the staflk regfion ffafifled to fimpflficate the known staflk regfion mutatfions, P1199L10,19 
or W1197X11, as both 1B3/9B9 and 1B8/9B9 bfindfing ratfios were sfimfiflar to patfients wfith normafl ACE flevefls 
(Ffig. 1B). We characterfized the pflasma ACE confformatfion ffrom subject #38 usfing a panefl off mAbs to 16 dfifferent 
epfitopes off human ACE to generate a “confformatfionafl ffngerprfint off ACE”20. Te fimmunoprecfipfitatfion profffle off 
pflasma ACE ffrom subject #38 was sfimfiflar, but not fidentficafl, to the “ffngerprfint” off pflasma ACE ffrom patfient wfith 
the Y465D mutatfion outsfide the staflk regfion (Ffig. S1A) that hfinders ACE dfimerfizatfion on the ceflfl surfface thereby 
fincreasfing ACE sheddfing13.
We next sequenced aflfl ACE exons and fidentfiffed the R532W substfitutfion fin the N domafin off the mature 
ACE protefin (Ffig. S1B). Tfis resfidue fis dfistant ffrom the staflk regfion and fis posfitfioned on the other sfide off the N 
domafin gflobufle ffrom the putatfive N domafin dfimer finterfface13. Subject #38 fis heterozygous ffor R532W mutatfion 
(Ffig. S1B) flfisted fin GenBank as rs4314 (htp:/www.ncbfi.nflm.nfih.gov/projects/SNP/) and ffound fin 5 out off 6220 
chromosomes tested.
Ffigure 1. ACE actfivfity and confformatfion fin pflasma sampfles. (A) ACE actfivfity fin 84 heparfinfized pflasma 
sampfles ffrom patfients wfith a varfiety off puflmonary dfiseases (Hfip-Hfis-Leu as ACE substrate). Data was 
expressed as the % off findfivfiduafl ACE actfivfity ffrom mean vaflue (green) ffor the heaflthy controfl group. Bflue bars 
-sampfles wfith ACE actfivfity hfigher than mean + 2SD. Red bar - the sampfle (#38) wfith putatfive ACE mutatfion. 
(B) ACE actfivfity, precfipfitated by mAbs 1B3 and 1B8 ffrom pflasma off patfient #38 and ffrom pflasma off subjects 
wfith dfifferent ACE mutatfions fidentfiffed prevfiousfly (W1197X11, P1199L10, Y465D13 and IVS25 + 1G > A12), 
was normaflfized to that precfipfitated wfith mAb 9B919. Lower flfine fin the flegend to B – country orfigfin off each 
mutatfion. Yeflflow bars-sampfles wfith mAb/9B9 ratfio flower than 80% off controfl. Red bars-sampfles wfith mAb/9B9 
ratfio hfigher than 20% off controfl *p < 0.05 fin comparfison wfith mean vaflue ffor controfl group.
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Western bflot anaflysfis on CHO ceflfls expressfing wfifld-type (WT) or mutant R532W ACEs demonstrated that 
thfis mutatfion ffafifled to efither aflter ACE expressfion or fimpact ACE dfimerfizatfion. We concfluded that hfigh pflasma 
ACE actfivfity fin subject #38, carrfier off ACE R532W mutatfion, fis flfikefly the resuflt off changes fin ACE sheddfing, pos-
sfibfly vfia confformatfionafl changes. Tfis possfibfiflfity was conffrmed by the confformatfionafl ffngerprfintfing off mutant 
R532W ACE, whfich reveafled mufltfipfle confformatfionafl changes fin the N and C domafins and a strfikfing decrease fin 
the bfindfing off mAb 6A12 (Ffig. S2), whfich finteracts wfith N domafin resfidue 532.
ACE-bfindfing bflood components reguflate ACE sheddfing. What fis the mechanfism off thfis novefl muta-
tfion fin the N domafin off ACE, very ffar ffrom the staflk regfion, where membrane-bound ACE fis cfleaved by a stfiflfl 
unfidentfiffed ACE secretase? How coufld thfis mutatfion change the rate off ACE sheddfing off the R532W mutant? 
We have demonstrated prevfiousfly, that the bfindfing off two mAbs to dfifferent, but overflappfing epfitopes on the N 
domafin off ACE, 9B9 and 3A5, ffar ffrom the finterfface off the N-domafin dfimer, fincfludfing Y465 resfidue, resuflts fin 
2–4 ffofld fincrease fin somatfic ACE sheddfing21. Tereffore, the confformatfionafl changes fin the N domafin off ACE, 
finduced by bfindfing off some mAbs, coufld flead to confformatfionafl changes fin the staflk regfion off somatfic ACE and 
thus enhance sheddfing off somatfic, two-domafin ACE21,22.
Dfiflutfion off human pflasma/serum (as weflfl as addfing ACE finhfibfitor) fled to the fincrease fin the reflatfive bfindfing 
off severafl mAbs to epfitopes on both N and C domafins off ACE (Ffig. 2A–C), whereas the bfindfing off these mAbs to 
recombfinant ACE or purfiffed ACE ffrom semfinafl ffufid was not changed upon dfiflutfion (not shown). We hypoth-
esfized that compound(s) fin the bflood can bfind to ACE, and, then, dfissocfiate durfing dfiflutfion. Tey coufld not be 
endogenous ACE finhfibfitors, because the most sfignfiffcant fincrease fin bfindfing upon dfiflutfion (whfich finduce dfisso-
cfiatfion off ACE finhfibfitors) was demonstrated ffor mAbs 1G12 and 6A12 (Ffig. 2), whereas the bfindfing off common 
ACE finhfibfitors to pflasma ACE, just an opposfite, dramatficaflfly fincreased the bfindfing off these mAbs, (Ffig. 2D). 
Tereffore, the bfindfing off mAbs 1G12 and 6A12 shoufld be decreased upon dfiflutfion and dfissocfiatfion off an finhfibfi-
tor ffrom the compflex wfith ACE. Effects off ACE substrates on mAbs 1G12/ 6A12 bfindfing to bflood ACE were more 
modest: AI and BK (+ 100%) and substance P (+ 50%) (p < 0.05, not shown), whfifle the effect off enaflaprfiflat was 
rather huge - + 300% (Ffig. 2D).
Te posfitfions off epfitopes, whose mAbs bfindfing to ACE fincreased upon dfiflutfion off the human pflasma, aflso 
gave some addfitfionafl finfformatfion. Hfighfly overflappfing epfitopes off mAbs 1G12 and 6A12 on the N domafin are 
flocated cflose to the epfitope ffor mAb 1E10 on the adjacent C domafin (Ffig. 3). Tereffore, fit fis possfibfle that an 
unknown compound(s) ffrom the bflood may bfind to ACE coverfing regfions on both ACE domafins (Ffig. 3), and 
subsequentfly dfissocfiate durfing dfiflutfion.
ACE sheddfing ffrom CHO-ACE ceflfls was finhfibfited 2–3-ffofld fin the presence off human and bovfine serum (Ffig. S3).  
R532W ACE sheddfing was comparabfle wfith that off wfifld-type ACE finto the serum-ffree medfium, whereas fin the 
presence off 10% off human serum the rate off sheddfing off mutant ACE was ~2.5-ffofld hfigher than WT ACE (Ffig. 
S3A), that fis, the decrease off ACE sheddfing caused by the presence off serum was fless pronounced ffor mutant ACE. 
We hypothesfized that pflasma/serum compounds, such as ACE-bfindfing protefin(s) and/or LMW components, 
stabfiflfize ACE confformatfion on the ceflfl surfface thus preventfing excessfive sheddfing, whfifle ACE mutant R532W 
exhfibfits dfimfinfished abfiflfity to bfind these compounds ffrom the serum and, thereffore, fis shed more effectfivefly.
Te effect off serum on the cfleavage/secretfion process off protefins ffrom endotheflfiafl ceflfls was studfied fin detafifl 
fin the past. Te totafl amount off protefins cfleaved ffrom thefir surfface, especfiaflfly hfigher MW protefins, dramatficaflfly 
fincreased fin the presence off serum, flfikefly due to protectfion off newfly refleased protefins ffrom degradatfion23. Serum 
was aflso shown to stfimuflate a cfleavage off some membrane protefins, fi.e. TNF-a precursor24. Te decreased ACE 
sheddfing fin the presence off serum findficates on a specfiffcfity off thfis effect, whfich can be dfirectfly connected to the 
hfigh flevefl off ACE fin the bflood off patfient wfith R532W mutatfion. Te rate off mutant ACE sheddfing fin a serum-ffree 
medfium was the same as ffor the wfifld-type ACE. In the presence off 10% off serum, however, fit was sfignfiffcantfly 
hfigher than that ffor WT ACE fin the same condfitfions (Ffig. S4A), that fis, the decrease off ACE sheddfing caused by 
the presence off serum was fless pronounced ffor mutant ACE.
We aflso compared the effects off compound BB-94 (batfimastat), as weflfl as mAbs 9B9 and 3A5 to ACE21, on 
WT and mutant ACE sheddfing ffrom CHO ceflfls. Impact off these compounds on ACE sheddfing fin serum-ffree 
medfium was fidentficafl ffor WT and mutant ACE, that fis, sfimfiflar fincrease off sheddfing. In the presence off 10% 
heat-finactfivated human serum, however, the effect off these compounds on ACE sheddfing was fless pronounced 
(about two-ffofld) ffor mutant ACE compared to WT ACE (p < 0.05, not shown).
Te hypothesfis about serum components, e.g. ACE-bfindfing protefin(s), whfich are abfle to stabfiflfize ACE con-
fformatfion thus preventfing an excessfive ACE sheddfing, flfikefly aflflows us to correctfly expflafin the weflfl-known effect 
off ACE finhfibfitor treatment, namefly, sfignfiffcant fincrease fin ACE flevefls fin the bflood off patfients25 and rats26,27. Te 
enhancement off ACE sheddfing ffrom CHO-ACE ceflfls and ffrom endotheflfiafl ceflfls by ACE finhfibfitor enaflaprfiflat 
was observed onfly fin the presence off serum (Ffig. S4B), whfich fis fin accordance wfith prevfious studfies on fisoflated 
human endotheflfiafl ceflfls28. We suggest that the bfindfing off ACE finhfibfitors to ACE on the surfface off endotheflfiafl 
ceflfls (or on CHO-ACE ceflfls) grown fin the presence off 10% serum finduces dfissocfiatfion off pflasma component(s)/
protefin(s) ffrom the compflex wfith ACE, whfich fis reffected by the sfignfiffcant fincrease fin mAbs 1G12 and 6A12 
bfindfing (Ffig. 2D). Te fincreased accessfibfiflfity off the epfitopes ffor these mAbs findficates that these epfitopes coufld be 
putatfive bfindfing sfites ffor thfis hypothetficafl compound(s). In a consequence off such dfissocfiatfion, ACE confforma-
tfion coufld be destabfiflfized and the rate off ACE sheddfing fincreased.
Tfis effect off enaflaprfiflat (and substance P, as an exampfle off ACE substrate) on ACE expressfion and ACE 
sheddfing was ffurther tested on severafl ACE expressfing ceflfls under serum-ffree growth condfitfions: artfiffcfiafl 
ACE-expressfing ceflfls, fi.e. CHO, HEK and Rat Lung Mficrovascuflar Endotheflfiafl Ceflfls (RLMVEC) transffected wfith 
recombfinant human ACE, and naturafl ACE-expressfing ceflfls, HUVEC29. Among these ceflfls, onfly HUVEC showed 
a modest fincrease fin surfface ACE expressfion by ~30% and a sfignfiffcant fincrease fin the rate off ACE sheddfing by 
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~150% affer 24 hours off fincubatfion wfith enaflaprfiflat (100 nM) fin serum-ffree medfium (p < 0.05, not shown) whfich 
fis fin accordance wfith prevfious studfies on fisoflated human endotheflfiafl ceflfls28. We thereffore consfider thfis ffact as 
an findficatfion that onfly HUVEC (ffrom tested ceflfls) coufld express thfis putatfive ACE-bfindfing compound/protefin, 
anaflogous to what, as we hypothesfize, fis present fin human pflasma.
Tereffore, the bfindfing off finhfibfitors to ACE resuflts fin confformatfionafl changes fin the ACE moflecufle (reffected 
by the afltered confformatfionafl ffngerprfint (Ffig. 2D). Tfis may finduce dfissocfiatfion off pflasma component/protefin 
Ffigure 2. Effect off pflasma dfiflutfion on mAbs bfindfing to bflood ACE. (A–C) Precfipfitatfion off ACE actfivfity 
ffrom pflasma sampfles was perfformed wfith 16 mAbs to dfifferent epfitopes off human ACE as fin Ffig. 1B usfing 
poofled human serum (ffrom 10 heaflthy findfivfiduafls) at dfifferent dfiflutfions, 1/2.5, 1/5, 1/10, and 1/20. (A,B) Data 
are expressed as a percentage off the ratfio off ACE actfivfity precfipfitatfion by chosen mAb at a gfiven dfiflutfion to that 
off 1/2.5 dfiflutfion (100%). (C) Effect off 8-ffofld dfifference fin dfiflutfion on ACE precfipfitatfion by aflfl 16 mAbs  
(1/2.5 dfiflutfion − 100%). (D) Effect off ACE finhfibfitor enaflaprfiflat (100 nM) on ACE precfipfitatfion by thfis set off 
mAbs. Data are mean + SD off trfipflficates. Bars hfighflfighted wfith orange and red - the vaflues off precfipfitated ACE 
actfivfity ffrom mutant ACE were more than 20% and 100% hfigher, respectfivefly, than these vaflues ffor WT. Yeflflow 
bars-sampfles wfith mAb/9B9 ratfio flower than 80% off controfl. Coflored bars findficate that the dfifferences fin ratfios 
are statfistficaflfly sfignfiffcantfly dfifferent (p < 0.05).
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ffrom the ACE compflex. As a consequence, ACE confformatfion on the ceflfl membrane coufld be destabfiflfized, 
thereby fincreasfing accessfibfiflfity off ACE to secretase.
Another argument to support the hypothesfis about stabfiflfizfing effect off bflood component (-s) on ACE con-
fformatfion and sheddfing fis the rate off sheddfing off the shorter, one-domafin testficuflar ACE (tACE). Tfis rate was 
Ffigure 3. Putatfive compflex off ACE wfith ACE-bfindfing protefin ffrom the bflood. A modefl off human somatfic 
ACE was constructed usfing the modefl off porcfine somatfic ACE based on eflectron mficroscopy (EM)59. 
Specfiffcaflfly, the EM modefl was superfimposed on the N domafin off human ACE (PDB 3NXQ). Te human  
C domafin (PDB 1O86) was then superfimposed on the C domafin off the EM modefl. Te epfitopes were marked 
on the N and C domafins as descrfibed prevfiousfly22,44,51,60–63. Epfitope mappfing on the N and C domafins was 
rendered fin Chfimera and PYMOL. Te posfitfion off R532W substfitutfion was shown by arrow. Putatfive ACE-
bfindfing protefin was docked to the cfleff between N and C domafins off the modefl off the two domafin human 
ACE fin a way that to mask epfitopes ffor mAbs 1G12/6A12 on the N domafin and epfitope ffor mAb 1E10 on the 
C-domafin.
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reported to be severafl tfimes hfigher fin comparfison wfith the ffuflfl-sfize, two domafin somatfic ACE (sACE), whfich 
was expressed under fidentficafl condfitfions fin CHO ceflfls30,31. Te authors proposed that the N-termfinafl domafin 
off sACE acts as a “confformatfionafl finhfibfitor” that sterficaflfly hfinders access to the staflk regfion ffor secretase30 or 
that the C-termfinafl domafin contafins a recognfitfion motfiff ffor ACE secretase that fis obscured by the N domafin fin 
somatfic ACE31.
Our data aflflows us to hypothesfize an addfitfionafl expflanatfion off a much hfigher rate off sheddfing off tACE. As 
sheddfing off both ACEs was estfimated fin the presence off 10% FBS, thfis dfifference coufld be due to fless tfight bfind-
fing off the hypothetficafl ACE-bfindfing serum component (ACE-bfindfing protefin) to the one-domafin tACE fisofform 
compared to the two-domafin sACE, whfich, fin turn, coufld flead to a hfigher rate off sheddfing off tACE. Tereffore, 
we tested the effect off sera on the sheddfing off both tACE and sACEs ffrom the surfface off CHO ceflfls - the sheddfing 
off ffuflfl-sfize, two-domafin ACE was dramatficaflfly finhfibfited by the presence off 10% serum, 34.5 + 6.5% ffrom that fin 
serum ffree-medfium, whfich was equafl to 20.2%/per24 hours (Ffig. S3). Te effect off human and bovfine sera (10%) 
on the sheddfing off tACE (whfich, findeed, had much hfigher rate off sheddfing fin serum-ffree condfitfions, 45.3%/
per 24 hours) was much fless pronounced, thfis rate befing equafl to 38.4 + 1.3%/per 24 hours fin the presence off 
sera, that fis, fit was dfimfinfished onfly by 15.3 + 2.6% ffrom the finfitfiafl vaflue (p < 0.05 ffor the effect off sera on sACE 
versus that on tACE). Tereffore, sfignfiffcantfly hfigher rate off testficuflar ACE sheddfing coufld aflso be expflafined by 
fless effectfive bfindfing off putatfive ACE-bfindfing component/protefin ffrom serum to one-domafin testficuflar ACE.
Lysozyme bfinds to ACE. What protefins fin the bflood potentfiaflfly bfind to ACE on the endotheflfiafl ceflfl sur-
fface? An unfidentfiffed ~14 kDa ACE-bfindfing protefin ffrom human bflood was prevfiousfly reported18. Our anafl-
ysfis off human serum proteome data32 reveafled severafl ACE-bfindfing candfidates fincfludfing β 2-mficrogflobuflfin 
(13.6 kDa), flysozyme (14.5 kDa), cystatfin C (13.4 kDa), transthyretfin (13.7 kDa), and serum amyflofid A protefin 
(13.5 kDa). We tested β 2-mficrogflobuflfin and flysozyme by conventfionafl technfiques utfiflfizfing protefin-coated mficr-
otfiter pflates ffoflflowed by fincubatfion wfith human pflasma. Potentfiafl ACE bfindfing was anaflyzed by precfipfitatfion off 
ACE actfivfity on the fimmobfiflfized protefins. We dfid not detect ACE bfindfing by β 2-mficrogflobuflfin, whfifle we regfis-
tered modest flysozyme bfindfing to ACE (Ffig. S5A). We next assessed dfirect protefin-protefin finteractfion off purfiffed 
flung ACE wfith these two pflasma protefins by surfface pflasmon resonance (BIACORE). Tese studfies vaflfidated that 
flysozyme, but not β 2–mficrogflobuflfin, bfinds to human ACE (Ffig. S5B).
ACE confformatfion was afltered by exogenous human flysozyme (Ffig. S6), fffindfings consfist wfith dfirect 
ACE-flysozyme finteractfion. Te epfitopes ffor the seflect mAbs that aflter bfindfing fin the presence off flysozyme are 
flocated on both N and C domafins aflflowfing us to concflude that flysozyme fforms compflexes wfith somatfic ACE by 
occupyfing the cfleff between domafins. However, the majorfity off the epfitopes ffor these mAbs are on the C domafin 
fincfludfing the epfitope ffor mAb 1E10 that coufld be vfiewed as a part off the dockfing area ffor flysozyme.
ACE finteractfion wfith flysozyme, a weflfl-studfied protefin, was unantficfipated and had not prevfiousfly been 
reported possfibfly reffectfing weak bfindfing constant off ACE-flysozyme finteractfion wfith very hfigh assocfiatfion 
and dfissocfiatfion rates off ACE-flysozyme compflex (Ffig. S5B) observed ffor ACE-casefinopeptfide finteractfions33. 
Conversefly, thfis may reffect the use off testficuflar ACE ffor co-fimmunoprecfipfitatfion fin prfior studfies14,15,17, whfich 
does not have a cfleff between domafins. Moreover, flow moflecuflar wefight protefins14 were unflfikefly to have been 
consfidered durfing co-precfipfitatfion experfiments.
To ffurther vaflfidate ACE-flysozyme finteractfion, we perfformed fimmunoprecfipfitatfion off CHO ceflfls express-
fing testficuflar (tACE) or somatfic (sACE) fisofforms off human ACE wfith antfi-ACE or antfi-flysozyme antfibodfies. 
Lysozyme was co-precfipfitated wfith both ACEs by antfi-ACE mAb, and both ACEs were co-precfipfitated wfith 
flysozyme by antfi-flysozyme antfibody (Ffig. 4). Fflow cytometry off CHO ceflfls expressfing both fisofforms off ACE 
wfith antfi-flysozyme mAbs (Ffig. S7) showed that CHO-sACE ceflfls pretreated wfith flysozyme expressed 30% hfigher 
amount off flysozyme on the ceflfl surfface than CHO-tACE ceflfls (Ffig. S7C). Tus, thfis fimpflfies two-domafin ACE 
possesses a more ffavorabfle dockfing area ffor flysozyme than the sfingfle-domafin fisofform.
Ffigure 4. Identfiffcatfion off flysozyme as ACE-assocfiated protefin. CHO ceflfls expressfing testficuflar (CHO-
tACE) and somatfic (CHO-ACE) fisofforms off ACE were pre-fincubated overnfight wfith human flysozyme or BSA 
(as negatfive controfl) at 250 µ g/mfl. Lysates off these ceflfls were precfipfitated wfith antfi-ACE and antfi-flysozyme 
antfibodfies. Representatfive Western bflots showed co-precfipfitatfion off ACE and flysozyme ffrom CHO-ACE ceflfls. 
Identficafl resuflts were obtafined fin two addfitfionafl experfiments.
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Te ACE-flysozyme finteractfion potentfiaflfly expflafins the paraflflefl fincrease fin bflood ACE and flysozyme con-
centratfions fin patfients wfith sarcofidosfis34,35 and fin patfients on cortficosterofid therapy9,35 We hypothesfize that 
flysozyme, whfich fis synthesfized and secreted mafinfly by ceflfls off myeflofid orfigfin36, bfinds to ACE, hfighfly expressed 
on macrophage and dendrfitfic ceflfl wfithfin sarcofid granuflomas5,20,37. Lysozyme may thereffore appear on the ceflfl 
membrane fin a compflex wfith ACE and subsequentfly shed finto the cfircuflatfion aflong wfith ACE.
Lysozyme reguflates ACE sheddfing fin vfivo. ACE phenotypfing off mfice wfith afltered flysozyme expressfion 
showed that cfircuflatfing ACE actfivfity was decreased (3-ffofld) onfly fin the sera off flysozyme M-deffcfient mfice (Ffig. S8) 
compared to sera ffrom WT mfice. Aflthough thfis resuflt appears to contradfict the hypothesfis that flysozyme stabfi-
flfizes ACE and reduce ACE sheddfing, thfis paradox fis addressed by the ffact that expressfion off flysozyme P fis dra-
matficaflfly fincreased fin flysozyme M knock-out mfice38, especfiaflfly fin the flung39. Tereffore, fit fis flogficafl to concflude 
that fin mfice flysozyme P (not flysozyme M) can bfind to ACE, stabfiflfize fits confformatfion, and thus, reduce ACE 
sheddfing.
CHO-ACE ceflfls transfientfly transffected wfith pflasmfid encodfing human flysozyme demonstrated decreased 
(3-ffofld) ACE sheddfing and recfiprocaflfly fincreased ACE content on the ceflfl-surfface (Ffig. 5). Tfis unambfiguousfly 
conffrms the dfirect effect off flysozyme on ACE sheddfing. Tfis effect fis sfimfiflar to the effect off β 2-mficrogflobuflfin 
on the fincrease fin surfface expressfion off the T ceflfl dfifffferentfiatfion antfigen40. Aflthough specuflatfive, ACE 
finhfibfitor-medfiated ACE sheddfing ffrom HUVEC observed even fin the absence off serum (these study and reffs 26,28) 
may reffect dfissocfiatfion off flysozyme, endogenousfly expressed by endotheflfiafl ceflfls41, ffrom the ACE compflex on 
the ceflfl surfface.
Prevfiousfly, we measured bflood ACE actfivfity fin dfifferent specfies42 and ffound that ACE flevefls may dfiffer 10–20 
ffofld. Data shown fin Ffigs S9 and S10 aflflowed us to finffer that dfifferences fin flysozyme amfino acfid sequences fin var-
fious specfies coufld determfine the abfiflfity off flysozymes to bfind to ACE and finffuence on ACE sheddfing. Tfis modefl 
Ffigure 5. Effect off flysozyme expressfion on ACE sheddfing. CHO-ACE ceflfls were transfientfly transffected 
wfith pflasmfids codfing ffor human flysozyme (HLZ) or ffor surffactant protefin C (SP-C as negatfive controfl). Affer 
48 hours, ACE actfivfity and flysozyme expressfion were quantfiffed fin the ceflfl flysates and fin the cuflture medfium. 
(A) Western bflotfing off flysate and cuflture medfium wfith antfi-human flysozyme Ab. Posfitfive controfl ffor the 
presence off flysozyme – human bronchoaflveoflar flavage ffufid (H. BALF). (B) Lysozyme muramfidase actfivfity fin 
the same sampfles was determfined usfing kfiflfled Mficrococcus flysodefitficus. (C) Soflubfle and ceflfl-bound ACE actfivfity 
was determfined wfith Z-Phe-Hfis-Leu as a substrate. Te rate off ACE sheddfing was caflcuflated as ACE actfivfity 
fin the cuflture medfium/the totafl amount off ceflfl-assocfiated and secreted ACE actfivfity. Data were expressed as a 
percentage ffrom negatfive controfl. Mean + SD off three experfiments.
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(Ffig. S10) does not excflude, however, the possfibfiflfity ffor other bflood protefins (ffrom 14 kDa flfist) to occupy the cfleff 
between domafins fin ACE gflobufle and aflso partficfipate fin reguflatfing ACE confformatfion and sheddfing.
Identfificatfion off a LMW bflood component that bfinds to ACE and reguflates fits sheddfing. We 
demonstrated that some flow moflecuflar wefight (LMW) human pflasma components aflso bfind to human ACE, 
fincfludfing endogenous ACE finhfibfitors (Ffig. S11) as weflfl as an unfidentfiffed LMW ACE effector whfich dfissocfiates 
ffrom bflood ACE durfing fffltratfion (Ffig. S12), dfiaflysfis (Ffig. S13), or dfiflutfion (Ffig. 2), and changes the bfindfing off 
mAbs 1G12 and 6A12 to the N domafin off ACE (Ffigs S12 and S13). Tfis LMW ACE effector fis hydrophobfic, 
weakfly negatfive (Ffig. S14), wfith a moflecuflar wefight fless than 3 kDa (Ffig. S13).
We tested the effects off human serum, depfleted off thfis effector by fffltratfion through a 3 kDa ffflter, on ACE 
sheddfing ffrom CHO-ACE ceflfls. Whfifle the 3 kDa serum fffltrate aflone dfid not affect ACE sheddfing (not shown), 
the rate off ACE sheddfing was 20–30% hfigher fin the presence off heat-finactfivated serum depfleted off 3 kDa com-
ponents compared to the whofle pre-heated serum (Ffig. S15). Tese data findficate that a specfiffc LMW effector 
partficfipates fin the reguflatfion off ACE sheddfing and the combfined effect off flysozyme and thfis novefl effector fin 
the human serum on ACE sheddfing fis more pronounced than wfith flysozyme aflone. Te effect off human pflasma 
3 kDa fffltrate on ACE confformatfion fis fin accordance wfith thfis finterpretatfion: thfis fffltrate changed the conffor-
matfion off both domafins off ACE fin human serum contafinfing flysozyme (Ffig. S16A), whereas fit changed onfly the 
confformatfion off the N domafin fin purfiffed ACE, mafinfly at the epfitopes ffor mAbs 1G12 and 6A12 (Ffig. S16B).
Te effect off ACE finhfibfitor, enaflaprfiflat, and EDTA on the confformatfion off ACE fin the bflood (contafinfing 
both flysozyme and LMW ACE effector) and on the confformatfion off recombfinant ACE, where both compounds 
are absent (Ffig. S17), as weflfl as the effect off chflorfide depfletfion (Ffig. S18), suggest that dfissocfiatfion off LMW ACE 
effector potentfiaflfly depends on the natfivfity off Zn++ - N domafin chflorfide bfindfing sfite finteractfion43.
To fidentfiffy the LMW ACE effector(s) present fin human bflood, the 3 kDa fffltrate off human cfitrated pflasma was 
anaflyzed by chromatography fin combfinatfion wfith a mAb bfindfing assay (Ffig. S19), as weflfl as mass spectrometry 
(Tabfle S1). Fractfions 33–34 fincreased precfipfitatfion off ACE actfivfity by mAb 1G12 (Ffig. S19) that can be atrfibuted 
to the actfion off endogenous ACE finhfibfitory peptfides44 (Tabfle S1), whereas ffractfions 36–37, as opposfite, decreased 
precfipfitatfion off ACE actfivfity by thfis mAb. Tese ffractfions, thereffore, contafined unknown ACE effector.
An anaflysfis off the ffractfions by mass spectrometry dfid not aflflow deffnfitfive fidentfiffcatfion off the ACE effectors 
ffrom human bflood as there were excessfive number off compounds (> 60 fin ffractfions 36–37, not shown). As an 
aflternatfive approach, we perfformed bfiofinfformatfic anaflysfis off the human metaboflome, contafinfing more than 
7000 compounds45, and fidentfiffed severafl candfidates (Tabfle S2), fincfludfing bfiflfirubfin, a prfimary candfidate due to 
the sfignfiffcant decrease fin bflood ACE flevefls observed fin ficterfic patfients, whfich finversefly correflates wfith bfiflfirubfin 
flevefls fin the bflood46. Bfiflfirubfin aflone decreased precfipfitatfion off flung ACE by severafl mAbs, fincfludfing mAbs 1G12 
and 6A12, sfimfiflar to the effect off 3 kDa fffltrate off human pflasma (Ffig. 6A–C). Tus, bfiflfirubfin potentfiaflfly bfinds to 
ACE and reguflates ACE confformatfion. Bfiflfirubfin aflone (as weflfl as the 3 kDa fffltrate), however, dfid not affect the 
rate off ACE sheddfing ffrom CHO-ACE ceflfls (not shown). Accordfing to our estfimatfion, ACE concentratfion fin the 
flung fis ~130 nM (and fin the bflood ~3 nM), whfifle the totafl bfiflfirubfin concentratfion fin the bflood fis about 200 µ M
(and ffree bfiflfirubfin fis 10% off thfis amount ~20 µ M) suggestfing the possfibfiflfity that the majorfity off ACE moflecufles 
are bound by bfiflfirubfin. Tfis woufld fimpfly a centrafl rofle ffor bfiflfirubfin bfindfing fin reguflatfion off ACE sheddfing.
Bfiflfirubfin, as weflfl as 3 kDa fffltrate off pflasma, afltered mAb 6A12 bfindfing to ACE mutant, R532W, much stronger 
than to WT ACE (Ffig. 6D,E). As the posfitfion off R532 fis flocated wfithfin the epfitope ffor mAb 6A12 (Ffig. 3), we 
hypothesfized that, whfifle the mutatfion has aflready changed the confformatfion off ACE fin the regfion off the epfitope 
ffor thfis mAb, the bfindfing off bfiflfirubfin ffurther dramatficaflfly changed the flocafl confformatfion off mutant ACE, thus 
preventfing the bfindfing off flysozyme to mutant ACE moflecufle, whfich, fin turn, resuflted fin fincreased ACE sheddfing.
Modeflfing off flysozyme-ACE finteractfion. We atrfibuted the sfingfle R532W substfitutfion fin the N domafin off 
ACE, fleadfing to sfignfiffcantfly fincreased ACE sheddfing, to gross confformatfionafl changes off somatfic, two-domafin 
ACE and the finabfiflfity ffor ACE to bfind bflood components (such as bfiflfirubfin and flysozyme), that normaflfly stabfi-
flfize ACE confformatfion on the ceflfl membrane.
Data on flysozyme sequence anaflysfis (Ffig. S9), effects off human serum and fits components (flysozyme and 
LMW fffltrate) on mAbs bfindfing to bflood and purfiffed ACEs (Ffig. 6, Ffigs S12–S19) fled us to propose a modefl 
off flysozyme and bfiflfirubfin dockfing to ACE (Ffig. 7). In thfis modefl, flysozyme prfimarfifly bfinds to the regfion off 
the epfitope ffor mAb 1E10 on the C domafin off ACE and occupfies the cfleff near the brfidge between N and C 
domafins touchfing the epfitopes 1G12/6A12 on the N domafin, whfifle bfiflfirubfin (or bfiflfirubfin conjugates, mono- and 
dfi-gflucoronfides) bfinds onfly to the N domafin off ACE, fin partficuflar, to the regfion off the epfitope ffor mAb 6A12 
contafinfing R532W. Our data findficate that flysozyme, flfikefly fin combfinatfion wfith bfiflfirubfin, bfinds to ACE “stapflfing” 
the domafins together and, thus, stabfiflfizes ACE confformatfion on the surfface off endotheflfiafl ceflfls, whfich, fin turn, 
mfitfigates ACE sheddfing finto the cfircuflatfion.
Te mechanfistfic finsfights finto ACE sheddfing eflucfidated may have cflfinficafl and bfioflogficafl sfignfiffcance. Ffirst, thfis 
may expflafin the flong-observed fincrease fin bflood ACE protefin fin patfients treated wfith ACE finhfibfitors25,26. We specuflate 
that dfissocfiatfion off flysozyme/bfiflfirubfin compflex ffrom ACE on the vascuflar surfface enabfles a confformatfionafl change 
upon ACE finhfibfitor bfindfing that subsequentfly fleads to fincreased ACE sheddfing by an as off yet unfidentfiffed secretase.
Te ACE-flysozyme/bfiflfirubfin hypothesfis may expflafin the paradoxficafl sfimufltaneous fincrease fin substance P 
and ACE concentratfion fin patfients wfith mfigrafine47: bfindfing off substance P (ACE substrate) to ACE aflso finduces 
dfissocfiatfion off flysozyme/bfiflfirubfin ffrom ACE, thus fleadfing to hfigher rates off ACE sheddfing.
Our data may aflso expflafin the flow flevefl off ACE fin urfine42, despfite hfigh ACE expressfion fin proxfimafl tubufle 
epfitheflfiafl ceflfls5. As flysozyme fis ffreefly fffltered at the gflomeruflus, and reabsorptfion occurs aflmost excflusfivefly fin the 
proxfimafl tubufle48, the huge flysozyme concentratfion there coufld stabfiflfize ACE on the surfface off tubufle epfitheflfiafl 
ceflfls thereby preventfing ACE sheddfing finto urfine.
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Ffinaflfly, the ACE-flysozyme hypothesfis may expflafin the paraflflefl fincrease fin bflood flysozyme and ACE flevefls observed 
fin patfients wfith sarcofidosfis, a systemfic granuflomatous dfisorder9,34,35. Lysozyme can be sfimpfly shed ffrom the surfface 
off dendrfitfic ceflfls finto the bflood as a compflex wfith ACE - whfich concentratfion fis exteremefly hfigh on these ceflfls20,37.
In concflusfion, we have fidentfiffed a novefl ACE mutatfion, R532W, whfich fis assocfiated wfith eflevated bflood ACE 
flevefls. Bfiflfirubfin and flysozyme were fidentfiffed as novefl ACE-bfindfing bflood components that act fin concert to 
reguflate ACE confformatfion and possfibfly finffuence ACE sheddfing. Together, these resuflts provfide novefl mecha-
nfistfic finsfights finto the eflevated bflood ACE flevefls observed fin patfients on ACE finhfibfitor therapy wfith addfitfionafl 
bfioflogficaflfly and cflfinficaflfly reflevant ramfiffcatfions.
MethodsStudy partficfipants. Te study was approved by the Instfitutfionafl Revfiew Boards off the Unfiversfity off Chficago 
and the Unfiversfity off Iflflfinofis at Chficago. Aflfl correspondfing procedures were carrfied out fin accordance wfith 
finstfitutfionafl gufideflfines. Efighty ffour patfients were chosen ffor the TRIDOM study off the genetfics off puflmonary 
dfiseases unreflated to thfis report. Affer provfidfing wrfiten finfformed consent ffrom aflfl patfients, cfitrated pflasma was 
obtafined ffrom patfients ffor determfinatfion off ACE actfivfity and fimmunochemficafl characterfizatfion off ACE. One 
patfient (#38) was ffound to have pflasma ACE actfivfity hfigher than 150 mU/mfl (normafl range 8–40 mU/mfl49).
As an exampfle off pure somatfic ACE, we aflso purfiffed ACE ffrom semfinafl ffufid accordfing to50. Semfinafl ffufid 
was obtafined ffrom ejacuflates that were coflflected by Dr. V. Evdokfimov (Instfitute off Uroflogy, Moscow Russfia) affer 
obtafinfing finfformed consent ffrom aflfl donors and procedure was approved by IRB off thfis finstfitutfion.
ACE actfivfity assay. ACE actfivfity fin serum/pflasma, homogenates off mfice flungs or cuflture ffflufids or 
flysates ffrom ACE-expressfing ceflfls was measured usfing a ffuorfimetrfic assay wfith two ACE substrates, 2 mM 
Z-Phe-Hfis-Leu or 5 mM Hfip-Hfis-Leu49. Brfieffy, 20–40 µ flaflfiquots off sampfles were added to 200 µ floff ACE sub-
strate and fincubated ffor the approprfiate tfime at 37 °C. Hfis-Leu product was quantfiffed vfia compflexfing wfith 
o-phtafldfiafldehyde.
Ffigure 6. Effect off bfiflfirubfin and 3 kDa fffltrate off human bflood pflasma on mAbs bfindfing to pure human 
flung ACE, recombfinant wfifld type ACE, and mutant, R532W. (A–C) Precfipfitatfion off ACE actfivfity ffrom 
sampfles was perfformed wfith 17 mAbs to dfifferent epfitopes off human ACE as fin Ffig. 1B. (A) Lung ACE actfivfity 
precfipfitatfion fin the presence off 150 ug/mfl bfiflfirubfin fis expressed as a percentage ffrom that wfithout bfiflfirubfin. 
(B) Lung ACE actfivfity precfipfitatfion fin the presence off 80% 3 kDa fffltrate off human pflasma fis expressed as a 
percentage ffrom that wfithout fffltrate. (C) Te ratfio off the effects off bfiflfirubfin and 3 kDa fffltrate to mAbs bfindfing 
to ACE. Effect off 150 µ g/mfl bfiflfirubfin (D) and 3 kDa fffltrate off human pflasma (E) on ACE actfivfity precfipfitatfion 
ffrom soflubfle recombfinant R532W mutant fin comparfison wfith wfifld-type ACE and fis expressed as a percentage 
ffrom the effect on WT ACE. Data are mean + SD off 3–8 experfiments (dependfing off mAbs and types off 
experfiments). Statfistficaflfly sfignfiffcant (p < 0.05) fincrease fin vaflues off more than 20% off controfl was hfighflfighted 
fin orange, decrease fin vaflues off more than 20% - fin yeflflow; decrease fin vaflues off more than 50% - fin bflue.
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Immunoflogficafl characterfizatfion off the mutant ACE (Pflate fimmunoprecfipfitatfion assay). Nfinety 
sfix-weflfl pflates (Cornfing, Cornfing, NY) were coated wfith antfi-ACE mAbs vfia goat antfi-mouse IgG (Pfierce, 
Rockfford, IL) brfidge51 and fincubated wfith tested ACEs. Ten pflate-bound ACE actfivfity was measured wfith sub-
strate ffor ACE (Z-Phe-Hfis-Leu) dfirectfly fin the weflfls51.
Sequencfing and genotypfing. Genomfic DNA was fisoflated ffrom the whofle bflood. Aflfl 26 exons off ACE gene 
were sequenced fin patfient #38 usfing pafirs off prfimers52. Affer the dfiscovery off the mutatfion (R532W), genotyp-
fing off the 100 unreflated findfivfiduafls ffor the search off the same mutatfion was perfformed by another PCR-based 
restrfictfion ffragment flength poflymorphfism assessment. Te 573 bp DNA ffragment was ampflfiffed by PCR wfith 
prfimers Ex11_CP29-CP30_R532W_Fw (TCACACCCTCAATCCACTTCTC, fintron 10) and Ex11_CP29-CP30_
R532W_Rv (ATTTGTGTCGCCCCATGCCAG, fintron 11) usfing genomfic DNA.
Te restrfictfion endonucflease AgeI cuts thfis 573 bp PCR product ffrom findfivfiduafl wfith natfive, wfifld-type ACE 
finto two ffragments off 347 and 226 bp. In the case off R532W substfitutfion, the restrfictfion sfite ffor thfis restrfictase 
dfisappeared and AgeI dfid not cut thfis PCR product.
Surfface Pflasmon Resonance (SPR). Interactfion off human ACE and human flysozyme was anaflyzed by 
SPR usfing optficafl bfiosensor Bfiacore 3000 (GE Heaflthcare, Pfiscataway, NJ) at 25 °C. Human ACE fisoflated ffrom 
human flung usfing affnfity chromatography on Lfisfinoprfifl-Sepharose as fin50 was fimmobfiflfized on the dextran sur-
fface off CM5 bfiosensor chfips by two approaches. In the 1st approach, ACE was covaflentfly coupfled to the dextran 
surfface off CM5 bfiosensor chfips to a densfity off 4000–5000 response unfits (RU) through amfine groups (accordfing 
to protocofl). In the 2nd approach, mAb to ACE, cflone 9B951, was covaflentfly coupfled to the dextran surfface off CM5 
bfiosensor chfips to a densfity off 4000–5000 response unfits (RU) through amfine groups, and then human ACE 
(500 nM) was appflfied over fimmobfiflfized mAb 9B9. Pure recombfinant human flysozyme, expressed fin rfice (L1667, 
Sfigma-Afldrfich, St. Loufis, MO) fin runnfing buffer (150 mM NaCfl, 20 mM HEPES, pH 7.4, 0.005% (v/v) surffactant 
P20), was appflfied over fimmobfiflfized ACE by finjectfion fin trfipflficate off varfious concentratfions (5 to 115 µ M) usfing a 
ffow rate off 20 µ fl mfin−1. In controfl experfiments, the conffguratfion was an opposfite: human flysozyme was fimmo-
bfiflfized on the bfiosensor and human flung ACE was appflfied over fimmobfiflfized flysozyme (as descrfibed above). Data 
were prepared by the method off “doubfle refferencfing” where paraflflefl finjectfions off anaflyte over a controfl dextran 
surfface were perfformed as weflfl as runnfing buffer finjectfions over both the fimmobfiflfized ACE and controfl dextran 
surffaces. To conffrm the specfiffcfity off ACE-flysozyme bfindfing, the ffoflflowfing purfiffed protefins were used finstead 
off flysozyme: human β 2–mficrogflobuflfin, B2M (Sfigma-Afldrfich, St. Loufis, MO), and bovfine serum aflbumfin, BSA 
(Pfierce, Rockfford, IL).
Ffigure 7. Te modefl off flysozyme/bfiflfirubfin dockfing to somatfic ACE. A modefl off human somatfic ACE was 
constructed usfing modefl off porcfine somatfic ACE59 - projectfions (A,B) Te epfitopes ffor mAbs were marked on 
ACE wfith cfircfles/eflflfipses, correspondfing to the epfitope sfize. Amfino acfid resfidues on the flysozyme structure 
(PDB 1W08): tested flysozyme mutatfion W64 - bflack spot; candfidates ffor bfindfing sfites to ACE (ffrom Ffig. S9 – red). 
Bfiflfirubfin (green) covers the R532 wfithfin the epfitope ffor mAb 6A12 and occupfies the finterspace between the 
N-domafin and flysozyme H78.
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Co-precfipfitatfion off ACE and other protefins. CHO ceflfls or CHO ceflfls, stabfly transffected wfith testfic-
uflar (CHO-tACE53) or somatfic (CHO-ACE54) fisofforms off human recombfinant ACE, were fincubated (at con-
ffuence) durfing 16 hours wfith Serum-Free Medfium (SFM) fin the absence or presence off 250 µ g/mfl off BSA or 
human recombfinant flysozyme (both Sfigma-Afldrfich, St. Lous, MO). Ceflfls were next washed wfith PBS, flysed 
fin Nonfidet flysfis buffer, pH 7.5, contafinfing 25 mM Trfis-HCfl, 150 mM NaCfl, 0.5% Nonfidet P40 (v/v) and pro-
tease finhfibfitor cocktafifl (EMD Mfiflflfipore, Bfiflflerfica, MA), fleff on fice ffor 30 mfin and centrfiffuged at 10 000g ffor 
5 mfin. Affer pre-cflearfing wfith protefin G Sepharose 4 Fast Fflow (GE Heaflthcare, Lfiffe Scfiences, Pfiscataway, New 
Jersey), protefins were fimmunoprecfipfitated ffrom the whofle ceflfl flysates wfith efither 1) antfi-ACE mAb 2B11 (cuflture 
ffufid, dfiflutfion 1/10), dfirected to an epfitope on the C domafin off ACE and thus recognfizfing both testficuflar and 
somatfic ACE55; or 2) rabbfit poflycflonafl antfibodfies to human flysozyme (Termo Scfientfiffc, Rockfford, IL, dfiflutfion 
1/50). Te fimmunoprecfipfitates affer fincubatfion wfith protefin-G-agarose beads, centrfiffugatfion and washfing (3X) 
wfith PBS-Tween (0.05%) were heated wfith SDS-PAGE sampfle buffer and separated on a gradfient SDS-PAGE 
(4–20%), transfferred onto Immobfiflon-P membranes, fimmunobfloted usfing prfimary mouse antfi-ACE mAb 
1D856 or rabbfit poflycflonafl antfi-flysozyme antfibodfies and, then, secondary antfibodfies, antfi-mouse-Horse Radfish 
Peroxfidase (HRP), and antfi-rabbfit-HRP, correspondfingfly, both at 1/2000 dfiflutfion (GE Heaflthcare, Lfitfle Chaflffont 
Buckfinghamshfire, UK). Vfisuaflfizatfion off fimmunoreactfive bands was achfieved by enhanced chemfiflumfinescence 
usfing ECL reagent (Amersham Bfioscfiences, Pfitsburgh, PA).
Fflow cytometry off CHO-ACE ceflfls. CHO-tACE or CHO-sACE ceflfls expressfing recombfinant fisofforms 
off human ACE were fincubated wfith tested mAbs at 4 °C ffor 60 mfin. Te ffoflflowfing mAbs were used: 1) mAb 
9B9 (10 µ g/mL) dfirected to an epfitope on the N domafin off ACE and thus recognfizfing somatfic ACE onfly51; 2) 
mAbs 4E3 and 2B11 (1/3 dfiflutfion off cuflture ffufid) dfirected to the epfitopes on the C domafin off ACE and thus 
recognfizfing both somatfic and testficuflar ACE55; 3) mAb to human flysozyme (10 µ g/mL), cflone BGN/06/961 (Cat. 
#MA1-83313-Termo Scfientfiffc Pfierce, Rockfford, IL). Ascfitfic ffufid ffrom mfice finjected wfith NS-1 mouse mye-
floma ceflfls (Cat. #M-8273, Sfigma-Afldrfich, St. Loufis, MO) was used as a source off non-fimmune mouse IgG as 
negatfive controfl. Ceflfls fincubated wfith the non-fimmune mouse IgG at the same concentratfion as the prfimary 
mAbs were processed fin paraflflefl to determfine the background ffuorescence. Ten ceflfls were washed wfith Hank’s 
Baflanced Saflt Soflutfion (HBSS, Ceflflgro, Manassas, VA) contafinfing 0.5% BSA and 2 mM EDTA. FITC-conjugated 
antfi-mouse IgG (5 µ g/mL, eBfioscfience, San Dfiego, CA) was then added at 4 °C ffor 30 mfin. Foflflowfing fincubatfion, 
ceflfls were washed and resuspended fin the HBSS buffer. Propfidfium fiodfide (PI) (eBfioscfience, San Dfiego, CA) 
at 1 µ g/mL concentratfion was added beffore Fflow CytoMetry (FCM) anaflysfis to fidentfiffy dead ceflfls. Sampfles were 
processed by an LSR Fortessa (Becton-Dfickfinson, FrankflfinLakes, NJ) and data were anaflyzed wfith the Summfit 
Soffware (Beckman Couflter, Inc., Fuflflerton, CA). Debrfis, cflumps (based on scaterfing characterfistfics) and dead 
ceflfls (based on fincflusfion off PI) were excfluded ffrom the anaflysfis. Te percentage off flysozyme- or ACE-posfitfive 
ceflfls was determfined by caflcuflatfion off the percentage off ceflfls havfing ffuorescence hfigher than ffuorescence off ceflfls 
fincubated wfith non-fimmune mouse IgG affer the subtractfion off background ffuorescence ffrom each hfistogram.
Mfice wfith afltered flysozyme expressfion. Aflfl fin vfivo mouse methods/experfiments were approved by and 
perfformed fin accordance wfith Cfincfinnatfi Chfifldren’s Hospfitafl Medficafl Center IACUC Commfitee gufideflfines and 
reguflatfions. Four groups off mfice, flysozyme-overexpressfing transgenfic mfice (flysozymetg), flysozyme M-deffcfient 
mfice (flysozyme M−/−), flysozyme M- and P-deffcfient mfice (flysozyme MP−/−), and strafin/age-matched wfifld-type 
(WT) mfice were used. Lysozymetg mfice (FVB/N strafin) were generated by targetfing expressfion off the rat 
flysozyme cDNA to the dfistafl respfiratory epfitheflfium under the dfirectfion off the 3.7-kb human surffactant protefin-C 
(SP-C) promoter57. Muramfidase (flysozyme) actfivfity was fincreased 16-ffofld fin the Broncho-Aflveoflar Lavage Fflufid 
(BALF) off transgenfic mfice reflatfive to WT mfice. Knock-out flysozyme M−/− mfice were generated fin the C57BL/6 
background by finsertfion off the gene encodfing enhanced green ffuorescent protefin finto the flys flocus, as prevfiousfly 
reported58, and were back-crossed 10 generatfions wfith FVB/N mfice to ffacfiflfitate comparfison wfith flysozymetg 
mfice. Lysozyme MP−/− mfice were generated fin the 129 Sv-Ev/Swfiss Bflack background and speed-bred ffve gener-
atfions finto the FVB/N background (Akfinbfi HT, unpubflfished). For each experfiment, 5- to 6-week ofld mfice were 
compared wfith WT FVB/N mfice.
Bfiofinfformatfic (fin sfiflfico) anaflysfis off thfis novefl ACE mutatfion. A modefl off human sACE was con-
structed usfing the modefl off porcfine sACE based on eflectron mficroscopy (EM)59. Arrangement off X-ray 3D den-
sfitfies off the N and C domafins (PDB-IDs: 3NXQ_chafin A and 1O86) finto the porcfine somatfic flung ACE eflectron 
mficroscopy modefl was perfformed 1) by aflfignment off N-termfinfi to north and C-termfinfi to south, aflong the 
flongfitudfinafl axfis off the ACE-modefl, 2) by setfing the domafins’ X-ray 3D densfitfies to 2,3 nm resoflutfion and fftfing 
them finto the ACE-modefl semfi-automatficaflfly wfith the “Ffit fin map” modufle, and 3) by shfifffing and rotatfing both 
domafins manuaflfly to re-aflfign them to the modefls flongfitudfinafl axfis and to aflflow the N-domafin Gflu590 resfidue to 
resfide proxfimafl to the C-domafin’s N-termfinus optfimfizfing the fft to the N and C domafin flfinkfing resfidues Vafl591 
to Gfly610 (“brfidge regfion”). Te epfitopes ffor mAbs to ACE were marked on the N and C domafins (Ffigs 3 and 7) 
accordfing to22,44,51,60–63.
Sfite-dfirected mutagenesfis and fin vfitro anaflysfis off the mutant ACEs. cDNAs encodfing mutant 
ACE protefin were created by GenScrfipt (Pfiscataway, NJ) by mutatfion off the GCG codon ffor Arg at posfitfion 532 
(somatfic mature ACE numberfing2) to codon TCG ffor Trp fin expressfion vector based on pcDNA3.1 + /Hygro 
(Invfitrogen Corp., Carflsbad, CA) and contafinfing the ffuflfl-flength somatfic ACE cDNA controflfled by CMV earfly 
promoter54. Pflasmfid DNA was sequenced and cflones wfith desfired mutatfion were seflected ffor each mutatfion.
Pflasmfids carryfing the codfing sequence ffor somatfic Wfifld-Type (WT) ACE and above mentfioned mutant were 
expressed fin CHO and HEK ceflfls usfing Pflus Reagent (Invfitrogen Corp., Carflsbad, CA) ffor transfient transffectfion 
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and generatfion off stabfle ceflfl flfines. Aflso ffor some experfiments we used CHO ceflfls transffected wfith 1) soflubfle 
somatfic ACE, WT∆ 64, 2) testficuflar fisofform off human ACE53; 3) truncated N domafin, D62965. Cuflture medfium 
(Ufltra-CHO medfium, Cambrex Bfio-Scfience, Waflkersvfiflfle, MD or serum-ffree DMEM, respectfivefly) ffrom these 
ceflfls was used as a source off the soflubfle ACE (wfifld type and mutants) ffor bfiochemficafl and fimmunoflogficafl char-
acterfizatfion. Lysate off these ceflfls was obtafined wfith detergent Trfiton X-100 (0.5% fin PBS) and used as a source off 
a mfixture off the membrane and soflubfle fforms off WT and mutant ACE. In some experfiments, Human Umbfiflficafl 
Vefin Endotheflfiafl Ceflfls (HUVEC) expressfing ACE at earfly passages29 were used.
Western bflot anaflysfis off mutant ACEs. Sampfles ffor SDS eflectrophoresfis were equfiflfibrated to ACE 
actfivfity off 200 mU/mfl (Hfip-Hfis-Leu as a substrate) and were run usfing gradfient (4–15%) Trfis-HCfl pre-cast SDS 
PAGE gefls (Bfio-Rad Laboratorfies, Hercufles, CA). Affer eflectrophoretfic transffer off protefins, the mficroporous 
PVDF-Pflus membranes were fincubated wfith mAbs to sequentfiafl epfitopes on human ACE, sufitabfle ffor detectfion 
off the denatured ACE, 3C5, 1D8, 5C860,65.
Co-transffectfion off CHO-ACE expressfing ceflfls wfith flysozyme cDNA. Pflasmfids carryfing the codfing 
sequence ffor human flysozyme (OrfiGene, Rockvfiflfle, MD) were transfientfly transffected fin CHO-ACE express-
fing ceflfls54 usfing flfipoffectamfine (Invfitrogen Corp., Carflsbad, CA) accordfing to manuffacturer’s recommendatfions. 
Cuflture medfium ffrom these ceflfls, contafinfing 10% off heat-finactfivated (65 °C, 30 mfin) Fetafl Bovfine Serum (FBS), 
was used as a source off the secreted (soflubfle) ACE ffor bfiochemficafl and fimmunoflogficafl characterfizatfion. Lysate off 
these ceflfls obtafined wfith flysfis buffer descrfibed above was used as a source off a mfixture off membrane and soflubfle 
fforms off ACE.
Statfistficafl anaflysfis. Te resuflts were consfidered to be statfistficaflfly sfignfiffcant when the flevefl off probabfiflfity 
was 0.05 or fless based on a non-parametrfic Mann-Whfitney U-test.
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